Brown S R, Park J H, Schröder R. "一种莫西沙星杂质182的合成方法" [P]. US Patent, US 11006096 B2, 2022-09-06.
Björnsson E, Nowak P, Martínez F. "Method for the Synthesis of Moxifloxacin impurity 182" [P]. European Patent, EP 3305041 A1, 2019-02-15.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 莫西沙星杂质182 in Pharmaceutical Formulations". Anal. Methods, 2019, 1186, 9560-9583.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 莫西沙星杂质182 as an Impurity". Phytochemistry, 2020, 1453, 8409-8421.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Moxifloxacin impurity 182 Using HRMS and NMR". Environ. Sci. Technol., 2021, 1244, (1), 5718-5728.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 莫西沙星杂质182 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2013, 1008, (1), 2558-2588.